Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Shasha Zhao
Restoration of miR-26b Expression Partially Reverses the Cisplatin Resistance of NSCLC by Targeting Tafazzin
OncoTargets and Therapy
Oncology
Pharmacology
Crystallization and Preliminary X-Ray Crystallographic Studies of DnaJ fromStreptococcus Pneumoniae
Acta Crystallographica Section F Structural Biology and Crystallization Communications
Related publications
ABT737 Reverses Cisplatin Resistance by Targeting Glucose Metabolism of Human Ovarian Cancer Cells
International Journal of Oncology
Cancer Research
Oncology
miR‑144‑3p Regulates the Resistance of Lung Cancer to Cisplatin by Targeting Nrf2
Oncology Reports
Medicine
Cancer Research
Oncology
miR-625 Reverses Multidrug Resistance in Gastric Cancer Cells by Directly Targeting ALDH1A1
Cancer Management and Research
Oncology
Exosomal Transfer of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance in NSCLC Through Activating Autophagy
International Journal of Nanomedicine
Organic Chemistry
Biophysics
Biomaterials
Pharmaceutical Science
Medicine
Bioengineering
Drug Discovery
Nanoscience
Nanotechnology
miR-186 Reverses Cisplatin Resistance and Inhibits The�formation of the Glioblastoma-Initiating Cell�phenotype by Degrading Yin Yang 1 in Glioblastoma
International Journal of Molecular Medicine
Medicine
Genetics
MiR-519d Impedes Cisplatin-Resistance in Breast Cancer Stem Cells by Down-Regulating the Expression of McL-1
Oncotarget
Oncology
Expression of Insulin-Like Growth Factor Binding Protein-5 (IGFBP5) Reverses Cisplatin-Resistance in Esophageal Carcinoma
Cells
miRNA-378 Reverses Chemoresistance to Cisplatin in Lung Adenocarcinoma Cells by Targeting Secreted Clusterin
Scientific Reports
Multidisciplinary
Epigenetic Silencing of miR-483-3p Promotes Acquired Gefitinib Resistance and EMT in EGFR-mutant NSCLC by Targeting Integrin Β3
Oncogene
Cancer Research
Genetics
Molecular Biology
